$37.060
-0.267 (-0.72%)收盤時
GRDN 資訊
GRDN 事件
Raises FY26 Adjusted EBITDA View to $129M-$131M
Raises FY26 adjusted EBITDA view to $129M-$131M from $122M-$127M
Guardian Reports Q2 Revenue of $351.8M, Beating Expectations
Reports Q2 revenue $351.8M, consensus $340.45M. "Guardian delivered another strong quarter, with continued momentum across our local markets," said Fred Burke, President and Chief Executive Officer. "While IRA-related pricing reductions affected reported revenue growth, which was up 2%, the underlying business remained strong. Absent the price reductions from the IRA, revenues would have been up low double digits compared to the second quarter of 2025. We also continued to expand profitability, reflecting the benefits of scale, purchasing leverage and improved operating efficiency."
Guardian Pharmacy Acquires Wellness Concepts to Expand Virginia Operations
Guardian Pharmacy Services announced the acquisition of Wellness Concepts, an LTC pharmacy based in Grottoes, Va. This addition expands Guardian's footprint in Virginia to three pharmacies in Gainesville, Wytheville, and Grottoes, strengthening its ability to support the growing demand for LTC pharmacy services across the state. "Since its founding, Wellness Concepts has earned the trust of communities throughout the Shenandoah Valley through exceptional service, strong customer relationships, and a deeply experienced local staff," said Marybeth Terry, Senior Vice President of the East Region at Guardian Pharmacy Services. "Welcoming Brent and his team strengthens our presence in Virginia and enhances the expertise and dependable, high-touch support we provide throughout the region."
Guardian Pharmacy Executive Forbes Retires, Morris to Become COO
Guardian Pharmacy Services announced that Kendall Forbes, who has served as Executive Vice President of Sales & Operations since 2004, has decided to retire, effective as of July 1. Upon Forbes's retirement, David Morris, currently Executive Vice President and CFO of Guardian will assume the role of COO. In connection with Morris' new role, Will Mudd, Senior Vice President, Finance, has been appointed CFO of Guardian. The leadership changes will be effective July 1. Mudd has served as Senior Vice President, Finance of the company since 2012, overseeing financial accounting and reporting, revenue cycle management, and human resources. Prior to joining Guardian, Mudd spent approximately ten years with the audit services group at Grant Thornton servicing a broad range of clients, ranging from small, private equity-backed private companies to mature public companies.
Q1 Revenue of $336.6M Exceeds Consensus
Reports Q1 revenue $336.6M, consensus $329.9M. "Our first quarter results reflect a strong start to the year and, importantly, a successful transition into a fundamentally new operating environment. While the Inflation Reduction Act (the "IRA") introduced significant pricing resets on certain branded medications that we dispense, we were able to offset the profitability impact, enabling us to maintain margin stability and deliver double-digit Adjusted EBITDA growth. Just as importantly, the underlying fundamentals of the business remain solid, with 10% growth in residents served and prescription volumes," said Fred P. Burke, President & CEO. "As the industry adapts to the broader effects of the IRA, we believe our scale, local operating model, and financial strength position us well to navigate ongoing changes and continue delivering consistent service to residents and our facility partners."
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。